EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Children with eosinophilic esophagitis non‐responsive to combination therapy have distinct esophageal transcriptomic and microbiome profile

Girish Hiremath iD, Yash Choksi iD, Hernan Correa, Justin Jacobse, Suman R Das, Siyuan Ma, Jeremy A Goettel, Seesandra V Rajagopala

Allergy · 2024

DOI: 10.1111/all.16208 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Allergy, 2024. Verfasst von Girish Hiremath und 7 weiteren Autor:innen. Beteiligte Einrichtung: Division of Pediatric Gastroenterology, Hepatology and Nutrition, Vanderbilt Children's Hospital, Vanderbilt University Medical Center, Nashville, Te…. Hauptthemen laut MEDLINE: Eosinophilic Esophagitis, Transcriptome, Proton Pump Inhibitors, Microbiota. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 47 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: BLRD VA, NIDDK NIH HHS, NIAID NIH HHS.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

A combination of proton‐pump inhibitors (PPI) and topical steroids (TS) is used to treat children with eosinophilic esophagitis (EoE). However, a subset of children do not respond to this combination therapy. We aimed to identify the esophageal transcriptional, cell composition, and microbial differences between the non‐responders (EoE‐PPI‐TSnr; n = 7) and responders (EoE‐PPI‐TSr; n = 7) to the combination therapy for EoE and controls ( n = 9) using metatranscriptomics.

Methods

Differential gene expression analysis was used to identify transcriptional differences, validated using the EoE diagnostic panel (EDP). Deconvolution analysis was performed to identify differences in their cell type composition. Microbiome analysis was conducted from esophageal biopsies RNAseq data, and microbial abundance was correlated with esophageal gene expression.

Results

In all, 3164 upregulated and 3154 downregulated genes distinguished EoE‐PPI‐TSnr from EoE‐PPI‐TSr. Eosinophilic inflammatory response, cytokine signaling, and collagen formation pathways were significantly upregulated in EoE‐PPI‐TSnr. There was a 56% overlap in dysregulated genes between EoE‐PPI‐TSnr and EDP, with a perfect agreement in the directionality of modulation. Eosinophils, dendritic cells (DCs), immature DCs, megakaryocytic‐erythroid progenitors, and T helper type 1 cells were significantly higher in EoE‐PPI‐TSnr. There was no significant difference in microbiome diversity. The relative abundance of Fusobacterium sp. and Acinetobacter sp. notably differed in EoE‐PPI‐TSnr and correlated with the key pathways.

Conclusion

Our results provide critical insights into the molecular, cellular, and microbial factors associated with the lack of response to PPI and TS combination therapy in children with EoE. This study advances our understanding of the pathobiology of EoE while guiding personalized treatment strategies.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Eosinophilic EsophagitisTranscriptomeProton Pump InhibitorsMicrobiotaHumansChildMaleFemaleEsophagusChild, PreschoolGene Expression ProfilingDrug Therapy, CombinationAdolescent

Stichwörter der Autor:innen

Metatranscriptomicseosinophilic esophagitisgene expressionimmune responsemicrobiome

Substanzen

Proton Pump Inhibitors

Autor:innen und Institutionen

  • Division of Pediatric Gastroenterology, Hepatology and Nutrition, Vanderbilt Children's Hospital, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Department of Medicine, Division of Gastroenterology, Hepatology and Nutrition, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Tennesee Valley Health System, Veteran's Affairs, Nashville, Tennessee, USA.
  • Division of Pathology, Vanderbilt Children's Hospital, Vanderbilt University Medical Center, Nashville, Tennessee, USA.
  • Willem-Alexander Children's Hospital, Department of Pediatrics, Leiden University Medical Center, Leiden, The Netherlands.
  • Department of Medicine, Division of Infectious Disease, Vanderbilt University Medical Center, Nashville, Tennessee, USA.

ORCID-Profile: Girish Hiremath, Yash Choksi

Förderung

  • BLRD VA
  • NIDDK NIH HHS
  • NIAID NIH HHS

Zitieren

APA

Hiremath, G., Choksi, Y., Correa, H., Jacobse, J., Das, S. R., Ma, S., Goettel, J. A., & Rajagopala, S. V. (2024). Children with eosinophilic esophagitis non‐responsive to combination therapy have distinct esophageal transcriptomic and microbiome profile. Allergy. https://doi.org/10.1111/all.16208

Vancouver

Hiremath G, Choksi Y, Correa H, Jacobse J, Das SR, Ma S, et al. Children with eosinophilic esophagitis non‐responsive to combination therapy have distinct esophageal transcriptomic and microbiome profile. Allergy. 2024. doi:10.1111/all.16208

BibTeX
@article{Hiremath2024,
  author = {Hiremath, Girish and Choksi, Yash and Correa, Hernan and Jacobse, Justin and Das, Suman R and Ma, Siyuan and Goettel, Jeremy A and Rajagopala, Seesandra V},
  title = {Children with eosinophilic esophagitis non‐responsive to combination therapy have distinct esophageal transcriptomic and microbiome profile},
  journal = {Allergy},
  year = {2024},
  doi = {10.1111/all.16208}
}
Kostenlos starten →